Please login to the form below

Not currently logged in


This page shows the latest CIC news and features for those working in and with pharma, biotech and healthcare.

Shire bags US approval for constipation drug Motegrity

Shire bags US approval for constipation drug Motegrity

Approval is boost as Takeda takeover nears completion. Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like ... It has the same mechanism as Trulance (plecanatide), which was

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Stepping up for Leeds Mind

    The Mednet Group consists of Attigo CIC and Mednet Ltd, two healthcare communications agencies focused on putting the patient first. Established in 2008, Mednet Group has grown into an award-winning ... Attigo CIC is a social enterprise that has the

  • CIC Solutions

    CIC Solutions are a Web Design and Development company based in Lancashire, UK, with a vast experience of the healthcare sector. ... CIC Solutions.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...